Larvol Delta - Avalon-GloboCare-Announces-Initiation-of-FirstinHuman-Clinical-Trial-of-its-CART-Candidate-AVA001-for-Treatment-of-BCell-Malignancies

AVA-001 - Avalon GloboCare

SENL-B19 - Hebei Senlang Biotechnology

http://www.globenewswire.com/news-release/2019/09/19/1917937/0/en/Avalon-GloboCare-Announces-Initiation-of-First-in-Human-Clinical-Trial-of-its-CAR-T-Candidate-AVA-001-for-Treatment-of-B-Cell-Malignancies.html

Sep 19, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next